Institution
Makati Medical Center
Also known as: MakatiMed · MMC
- 7running trials
- 8closed trials
- 780publications (OpenAlex)
Running trials
Recruiting
Recruiting
Active, not recruiting
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
Enrolling by invitation
Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Cervical cancer1 recruiting
- Lupus (SLE)1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
Completed
Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients
Completed
Completed
Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories
Completed
Completed
Completed
Completed
Registry name variants (4)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Makati Medical Center
Makati, 01229
7 trials
Makati Medical Center
Makati City, National Capital Region 1229
7 trials
Makati Medical Center (Site 1609)
Makati City, National Capital Region 1229
1 trial
Contact: Study Coordinator
Makati Medical Center (Site 2503)
Makati City, National Capital Region 1229
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Dystonia10 works · 0 trials
Institution data: ROR 02jy1hx10 (CC0-1.0)Updated 15 Nov 2026